Avantax Planning Partners’s Medifast MED Stock Holding History

Avantax Planning Partners’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7	Closed	-$1K	–	961
2018 Q1	$1K	Buy	+7	New	+$523	﹤0.01%	1723

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Avantax Planning Partners's MED Position: Q2 2018 in Review

Avantax Planning Partners sold out of Medifast (MED) in Q2 2018, closing a stake of 7 shares — an estimated $1K sold.

Avantax Planning Partners first reported a position in MED in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 258 funds tracked by Wall St. Rank hold MED as of Q2 2018.

Avantax Planning Partners reported no remaining Medifast position as of Q2 2018 after selling out during the quarter.
Avantax Planning Partners sold 7 Medifast shares in Q2 2018, an estimated $1K.
Avantax Planning Partners first reported a position in Medifast in Q1 2018 and held it in 1 quarter.
Avantax Planning Partners's Medifast position peaked at $1K in Q1 2018.
258 funds tracked by Wall St. Rank held Medifast as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.